Exane Derivatives’s Rite Aid Corporation RAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$20 Hold
3
﹤0.01% 756
2022
Q1
$26 Hold
3
﹤0.01% 1010
2021
Q4
$44 Hold
3
﹤0.01% 873
2021
Q3
$43 Hold
3
﹤0.01% 1036
2021
Q2
$42 Hold
3
﹤0.01% 1038
2021
Q1
$61 Hold
3
﹤0.01% 866
2020
Q4
$47 Hold
3
﹤0.01% 812
2020
Q3
$28 Hold
3
﹤0.01% 742
2020
Q2
$51 Hold
3
﹤0.01% 674
2020
Q1
$45 Hold
3
﹤0.01% 683
2019
Q4
$38 Hold
3
﹤0.01% 668
2019
Q3
$21 Buy
+3
New +$22 ﹤0.01% 649
2019
Q2
Hold
0
-$2 737
2019
Q1
Hold
0
636
2018
Q4
Hold
0
667
2018
Q3
Hold
0
688
2018
Q2
Hold
0
681
2018
Q1
Hold
0
621
2017
Q4
Hold
0
604
2017
Q3
Hold
0
564
2017
Q2
Hold
0
625
2017
Q1
Hold
0
-$25 695
2016
Q4
Hold
0
607
2016
Q3
Hold
0
598
2016
Q2
Hold
0
523
2016
Q1
Hold
0
569
2015
Q4
Hold
0
483
2015
Q3
Sell
-12
Closed -$2K 518
2015
Q2
$1.97K Hold
12
﹤0.01% 417
2015
Q1
$2.05K Sell
12
-335
-97% -$52.2K ﹤0.01% 420
2014
Q4
$52.1K Buy
+347
New +$38.5K 0.01% 322

Other funds holding RAD

Exane Derivatives's RAD Position: Q2 2022 in Review

Exane Derivatives held its Rite Aid Corporation (RAD) position steady in Q2 2022 at 3 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #756.

Exane Derivatives first reported a position in RAD in Q4 2014 and has held it in 15 quarters since. The position peaked at $52.1K in Q4 2014. 180 funds tracked by Wall St. Rank hold RAD as of Q2 2022.

  • Exane Derivatives held 3 shares of Rite Aid Corporation worth $20 as of Q2 2022.
  • Exane Derivatives left its Rite Aid Corporation share count unchanged in Q2 2022.
  • Rite Aid Corporation made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #756 holding.
  • Exane Derivatives first reported a position in Rite Aid Corporation in Q4 2014 and has held it in 15 quarters since.
  • Exane Derivatives's Rite Aid Corporation position peaked at $52.1K in Q4 2014.
  • 180 funds tracked by Wall St. Rank held Rite Aid Corporation as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.